Department of Medical Oncology;
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital;
Chinese Academy of Medical Sciences and Peking Union Medical College;
Beijing 100021;
China;
triple-negative breast cancer; immunotherapy; targeted therapy;